259 related articles for article (PubMed ID: 12831342)
21. Olanzapine: a review of its use in the treatment of bipolar I disorder.
Bhana N; Perry CM
CNS Drugs; 2001; 15(11):871-904. PubMed ID: 11700151
[TBL] [Abstract][Full Text] [Related]
22. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.
Corya SA; Williamson D; Sanger TM; Briggs SD; Case M; Tollefson G
Depress Anxiety; 2006; 23(6):364-72. PubMed ID: 16710853
[TBL] [Abstract][Full Text] [Related]
23. Clinical highlights in bipolar depression: focus on atypical antipsychotics.
Calabrese JR; Elhaj O; Gajwani P; Gao K
J Clin Psychiatry; 2005; 66 Suppl 5():26-33. PubMed ID: 16038599
[TBL] [Abstract][Full Text] [Related]
24. Treatment of bipolar depression: making sensible decisions.
Citrome L
CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
[TBL] [Abstract][Full Text] [Related]
25. Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition.
Poyurovsky M; Pashinian A; Gil-Ad I; Maayan R; Schneidman M; Fuchs C; Weizman A
Am J Psychiatry; 2002 Jun; 159(6):1058-60. PubMed ID: 12042201
[TBL] [Abstract][Full Text] [Related]
26. Improving identification of treatment effectiveness in bipolar disorders.
Bowden CL
Bipolar Disord; 2003 Apr; 5(2):77-8. PubMed ID: 12680895
[No Abstract] [Full Text] [Related]
27. [Olanzapine: a second generation antipsychotic drug and an "atypical" mood stabilizer?].
Bánki CM
Psychiatr Hung; 2007; 22(4):311-20. PubMed ID: 18167425
[TBL] [Abstract][Full Text] [Related]
28. Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies.
Tohen M; Case M; Trivedi MH; Thase ME; Burke SJ; Durell TM
J Clin Psychiatry; 2010 Apr; 71(4):451-62. PubMed ID: 20361905
[TBL] [Abstract][Full Text] [Related]
29. Atypical antipsychotics in bipolar depression: potential mechanisms of action.
Yatham LN; Goldstein JM; Vieta E; Bowden CL; Grunze H; Post RM; Suppes T; Calabrese JR
J Clin Psychiatry; 2005; 66 Suppl 5():40-8. PubMed ID: 16038601
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy of atypical antipsychotics in depressive syndromes].
Quintin P; Thomas P
Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
[TBL] [Abstract][Full Text] [Related]
31. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study.
Stein MB; Kline NA; Matloff JL
Am J Psychiatry; 2002 Oct; 159(10):1777-9. PubMed ID: 12359687
[TBL] [Abstract][Full Text] [Related]
32. Olanzapine: an atypical antipsychotic for schizophrenia.
Lund BC; Perry PJ
Expert Opin Pharmacother; 2000 Jan; 1(2):305-23. PubMed ID: 11249551
[TBL] [Abstract][Full Text] [Related]
33. The impact of response to previous mood stabilizer therapy on response to olanzapine versus placebo for acute mania.
Baker RW; Goldberg JF; Tohen M; Milton DR; Stauffer VL; Schuh LM
Bipolar Disord; 2002 Feb; 4(1):43-9. PubMed ID: 12047494
[TBL] [Abstract][Full Text] [Related]
34. Olanzapine: another psychotropic?
Davis MP; Dickerson ED
Am J Hosp Palliat Care; 2001; 18(2):129-32. PubMed ID: 11407129
[TBL] [Abstract][Full Text] [Related]
35. An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses.
Matthews JD; Bottonari KA; Polania LM; Mischoulon D; Dording CM; Irvin R; Fava M
J Clin Psychiatry; 2002 Dec; 63(12):1164-70. PubMed ID: 12523877
[TBL] [Abstract][Full Text] [Related]
36. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.
Brown EB; McElroy SL; Keck PE; Deldar A; Adams DH; Tohen M; Williamson DJ
J Clin Psychiatry; 2006 Jul; 67(7):1025-33. PubMed ID: 16889444
[TBL] [Abstract][Full Text] [Related]
37. [Augmentation of selective serotonin reuptake inhibitors (SSRI) with atypical antipsychotics in the treatment of depression].
Weimer E; Braus DF; Cavus I; Thome J
Fortschr Neurol Psychiatr; 2002 Apr; 70(4):210-7. PubMed ID: 11948436
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of acute bipolar disorder. Intriguing balancing act between mania and depression].
Grunze H; Dittmann S
MMW Fortschr Med; 2003 May; 145 Suppl 2():27-30. PubMed ID: 14579481
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis.
Oliva V; Possidente C; De Prisco M; Fico G; Anmella G; Hidalgo-Mazzei D; Murru A; Fanelli G; Fabbri C; Fornaro M; de Bartolomeis A; Solmi M; Radua J; Vieta E; Serretti A
Lancet Psychiatry; 2024 Mar; 11(3):210-220. PubMed ID: 38360024
[TBL] [Abstract][Full Text] [Related]
40. Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label study.
Corya SA; Andersen SW; Detke HC; Kelly LS; Van Campen LE; Sanger TM; Williamson DJ; Dubé S
J Clin Psychiatry; 2003 Nov; 64(11):1349-56. PubMed ID: 14658950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
